1. Home
  2. GLMD vs FEBO Comparison

GLMD vs FEBO Comparison

Compare GLMD & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • FEBO
  • Stock Information
  • Founded
  • GLMD 2000
  • FEBO 1993
  • Country
  • GLMD Israel
  • FEBO Hong Kong
  • Employees
  • GLMD N/A
  • FEBO N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • FEBO
  • Sector
  • GLMD Health Care
  • FEBO
  • Exchange
  • GLMD Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • GLMD 7.9M
  • FEBO 8.0M
  • IPO Year
  • GLMD 2014
  • FEBO 2023
  • Fundamental
  • Price
  • GLMD $1.49
  • FEBO $0.66
  • Analyst Decision
  • GLMD Hold
  • FEBO
  • Analyst Count
  • GLMD 1
  • FEBO 0
  • Target Price
  • GLMD N/A
  • FEBO N/A
  • AVG Volume (30 Days)
  • GLMD 164.0K
  • FEBO 21.2K
  • Earning Date
  • GLMD 09-02-2025
  • FEBO 09-02-2025
  • Dividend Yield
  • GLMD N/A
  • FEBO N/A
  • EPS Growth
  • GLMD N/A
  • FEBO N/A
  • EPS
  • GLMD N/A
  • FEBO N/A
  • Revenue
  • GLMD N/A
  • FEBO $17,110,653.00
  • Revenue This Year
  • GLMD N/A
  • FEBO N/A
  • Revenue Next Year
  • GLMD N/A
  • FEBO N/A
  • P/E Ratio
  • GLMD N/A
  • FEBO N/A
  • Revenue Growth
  • GLMD N/A
  • FEBO 11.58
  • 52 Week Low
  • GLMD $1.15
  • FEBO $0.61
  • 52 Week High
  • GLMD $23.80
  • FEBO $8.50
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 44.36
  • FEBO 26.66
  • Support Level
  • GLMD $1.35
  • FEBO $0.61
  • Resistance Level
  • GLMD $1.59
  • FEBO $0.76
  • Average True Range (ATR)
  • GLMD 0.11
  • FEBO 0.06
  • MACD
  • GLMD 0.00
  • FEBO -0.00
  • Stochastic Oscillator
  • GLMD 44.56
  • FEBO 22.22

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: